MarketBeat Daily Ratings for Wednesday, February 19, 2025
Ratings changes for Aurinia Pharmaceuticals, Oramed Pharmaceuticals, Fiserv, ClearOne, Aethlon Medical, Enanta Pharmaceuticals, Bank of South Carolina and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.February 19th, 2025 Today's Top Stories | | By Chris Markoch | February 19, 2025 06:17 AM |
| | | By The Associated Press | February 19, 2025 08:25 AM |
| | By Gabriel Osorio-Mazilli | February 19, 2025 06:50 AM |
| | | By The Associated Press | February 19, 2025 08:20 AM |
| | By Leo Miller | February 19, 2025 08:02 AM |
|
|
| Is this Elon’s true agenda? (ad)All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them
Click here for my report |
|
Analysts' Upgrades | | Airbnb (NASDAQ:ABNB) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $156.86. | | Brighthouse Financial (NASDAQ:BHF) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $59.00 price target on the stock, up previously from $41.00. This represents a 6.8% downside from the current price of $63.28. | | Capital One Financial (NYSE:COF) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $235.00 price target on the stock, up previously from $207.00. This represents a 15.1% upside from the current price of $204.09. | | CervoMed (NASDAQ:CRVO) was upgraded by analysts at D. Boral Capital from a "hold" rating to a "buy" rating. They now have a $10.00 price target on the stock. This represents a 339.6% upside from the current price of $2.28. | | Glaukos (NYSE:GKOS) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $200.00 price target on the stock, up previously from $140.00. This represents a 28.2% upside from the current price of $156.05. | | Illinois Tool Works (NYSE:ITW) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating. They now have a $257.00 price target on the stock. This represents a 1.8% downside from the current price of $261.82. | | NetApp (NASDAQ:NTAP) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $128.00 price target on the stock, up previously from $121.00. This represents a 5.3% upside from the current price of $121.54. | | STMicroelectronics (NYSE:STM) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $25.73. | | Travelers Companies (NYSE:TRV) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $286.00 price target on the stock, up previously from $275.00. This represents a 18.4% upside from the current price of $241.64. |
|
View More Upgrades
|
Analysts' Downgrades | | Axon Enterprise (NASDAQ:AXON) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating.The current price is $706.25. | | Baidu (NASDAQ:BIDU) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.The current price is $88.62. | | Essential Properties Realty Trust (NYSE:EPRT) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $33.50 price target on the stock, up previously from $29.50. This represents a 6.5% upside from the current price of $31.45. | | Golar LNG (NASDAQ:GLNG) was downgraded by analysts at DNB Markets from a "buy" rating to a "hold" rating.The current price is $40.61. | | Qiagen (NYSE:QGEN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $52.00. This represents a 7.4% upside from the current price of $39.11. | | SpartanNash (NASDAQ:SPTN) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating. They now have a $10.00 price target on the stock. This represents a 48.1% downside from the current price of $19.29. | | Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock, down previously from $57.00. This represents a 6.2% upside from the current price of $33.90. | | Tactile Systems Technology (NASDAQ:TCMD) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $18.00 price target on the stock, down previously from $23.00. This represents a 14.3% upside from the current price of $15.75. | | Bio-Techne (NASDAQ:TECH) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $68.00 price target on the stock, down previously from $88.00. This represents a 5.1% upside from the current price of $64.70. | | Tri Pointe Homes (NYSE:TPH) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $37.00 price target on the stock, down previously from $41.00. This represents a 19.2% upside from the current price of $31.04. | | Valmont Industries (NYSE:VMI) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $380.00 price target on the stock. This represents a 3.2% upside from the current price of $368.05. | | Workday (NASDAQ:WDAY) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $275.00 price target on the stock, down previously from $330.00. This represents a 7.2% upside from the current price of $256.50. |
|
View More Downgrades
|
Analysts' New Coverage | | Candel Therapeutics (NASDAQ:CADL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock. This represents a 99.2% upside from the current price of $10.04. | | Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $12.00 price target on the stock. This represents a 257.7% upside from the current price of $3.36. | | Coincheck Group (NASDAQ:CNCK) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock. This represents a 35.1% upside from the current price of $7.40. | | Electronic Arts (NASDAQ:EA) is now covered by analysts at DA Davidson. They set a "neutral" rating and a $140.00 price target on the stock. This represents a 7.7% upside from the current price of $130.04. | | GE Vernova (NYSE:GEV) is now covered by analysts at CICC Research. They set an "outperform" rating on the stock.The current price is $368.00. | | KT (NYSE:KT) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.The current price is $17.21. | | Lightspeed Commerce (NYSE:LSPD) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $20.00 price target on the stock. This represents a 44.2% upside from the current price of $13.87. | | SK Telecom (NYSE:SKM) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.The current price is $22.31. | | Stanley Black & Decker (NYSE:SWK) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $103.00 price target on the stock. This represents a 18.1% upside from the current price of $87.21. | | UroGen Pharma (NASDAQ:URGN) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $31.00 price target on the stock. This represents a 189.2% upside from the current price of $10.72. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Apple-SpaceX Deal Sets Stage for Mode's Global Takeover |
